Production of recombinant medicines is the major experimental research carried out in animal biotechnology studies. A surprising improvement in drug biotechnology in Iran is Interferon-beta 1a synthesis, one of the most expensive recombinant drugs in bio-pharmaceutics. Iranian researchers have succeeded in synthesis and fabrication of this drug with commercial name CinnoVex. The product has been launched in three countries and has an annual sale of nearly 18 million US dollars.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
Last date updated on July, 2014
